ArticleNanomedicine (London, England)2025

Dox-HCl and miR-145 co-delivery through CD44-targeted PEGylated liposomes inhibit Breast Cancer

Chu Xin Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.